​

Pyxis Oncology (PYXS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

PYXS Stock Forecast

Pyxis Oncology (PYXS) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a 47.06% increase from the last price of $3.40.

$1 $2 $3 $4 $5 $6 $7 High: $5 Avg: $5 Low: $5 Last Closed Price: $3.4

PYXS Stock Rating

Pyxis Oncology stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (66.67%), 2 Hold (33.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 2 4 0 Strong Sell Sell Hold Buy Strong Buy

PYXS Price Target Upside V Benchmarks

TypeNameUpside
StockPyxis Oncology47.06%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-11
Avg Price Target-$5.00$5.00
Last Closing Price$3.40$3.40$3.40
Upside/Downside-47.06%47.06%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25251--8
Sep, 25241--7
Aug, 25241--7
Jul, 25241--7
Jun, 25241--7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 04, 2025Guggenheim$5.00$1.61210.56%47.06%
Aug 16, 2024Swayampakula RamakanthH.C. Wainwright$7.00$3.5298.86%105.88%
Aug 07, 2024Bradley CaninoStifel Nicolaus$10.00$3.13219.49%194.12%
May 07, 2024Farzin HaqueJefferies$10.00$4.31132.02%194.12%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 03, 2025GuggenheimBuyinitialise
Dec 20, 2024RBC CapitalOutperformOutperformhold
Aug 16, 2024H.C. WainwrightBuyBuyhold
Sep 05, 2023RBC CapitalOutperforminitialise
Apr 25, 2022Zacks Investment ResearchHoldupgrade

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.85$-1.32----
Avg Forecast$-1.96$-1.09$-1.30$-1.25$-1.29$-1.36
High Forecast$-1.69$-1.06$-1.04$-0.90$-0.89$-1.36
Low Forecast$-2.11$-1.13$-1.47$-1.53$-1.99$-1.36
Surprise %-5.61%21.10%----

Revenue Forecast

$0 $7M $14M $21M $28M $35M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$16.15M----
Avg Forecast$166.67K$16.12M$400.00K$6.25M$15.54M$32.75M
High Forecast$166.67K$16.22M$400.00K$6.25M$15.54M$32.75M
Low Forecast$166.67K$16.07M$400.00K$6.25M$15.54M$32.75M
Surprise %-0.19%----

Net Income Forecast

$-85M $-75M $-65M $-55M $-45M $-35M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-73.79M$-77.33M----
Avg Forecast$-73.79M$-43.78M$-50.09M$-48.55M$-57.28M$-54.27M
High Forecast$-67.27M$-42.30M$-41.68M$-35.86M$-35.34M$-54.27M
Low Forecast$-84.19M$-45.26M$-58.51M$-61.24M$-79.22M$-54.27M
Surprise %-76.64%----

PYXS Forecast FAQ

Is Pyxis Oncology stock a buy?

Pyxis Oncology stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Pyxis Oncology is a favorable investment for most analysts.

What is Pyxis Oncology's price target?

Pyxis Oncology's price target, set by 6 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential 47.06% change from the previous closing price of $3.4.

How does Pyxis Oncology stock forecast compare to its benchmarks?

Pyxis Oncology's stock forecast shows a 47.06% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Pyxis Oncology over the past three months?

  • October 2025: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 28.57% Strong Buy, 57.14% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 28.57% Strong Buy, 57.14% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.

What is Pyxis Oncology’s EPS forecast?

Pyxis Oncology's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.3, marking a -1.52% decrease from the reported $-1.32 in 2024. Estimates for the following years are $-1.25 in 2026, $-1.29 in 2027, and $-1.36 in 2028.

What is Pyxis Oncology’s revenue forecast?

Pyxis Oncology's average annual revenue forecast for its fiscal year ending in December 2025 is $400K, reflecting a -97.52% decrease from the reported $16.15M in 2024. The forecast for 2026 is $6.25M, followed by $15.54M for 2027, and $32.75M for 2028.

What is Pyxis Oncology’s net income forecast?

Pyxis Oncology's net income forecast for the fiscal year ending in December 2025 stands at $-50.092M, representing a -35.22% decrease from the reported $-77.331M in 2024. Projections indicate $-48.547M in 2026, $-57.276M in 2027, and $-54.27M in 2028.